Showing results (141-150 of 187) with videos related to
Sort By:
Pageof 19
Neurology. Genetics|February 12, 2020
Psychometric properties of the Friedreich Ataxia Rating ScaleChristian Rummey, Louise A Corben, Martin B Delatycki, et al.Haematologica|January 2, 2016
Whole exome sequencing reveals a C-terminal germline variant in CEBPA-associated acute myeloid leukemia: 45-year follow up of a large familyAnand Pathak, Katja Seipel, Alexander Pemov, et al.The Lancet. Neurology|June 17, 2026
Safety and efficacy of levacetylleucine in ataxia-telangiectasia: a phase 3, randomised, double-blind, placebo-controlled crossover trialKyriakos Martakis, Tatiana Bremova-Ertl, Clare Bolton, et al.Movement Disorders : Official Journal of the Movement Disorder Society|November 29, 2022
Efficacy of Omaveloxolone in Friedreich's Ataxia: Delayed-Start Analysis of the MOXIe ExtensionDavid R Lynch, Melanie P Chin, Sylvia Boesch, et al.Neurology. Genetics|August 2, 2017
Prevalence of spinocerebellar ataxia 36 in a US populationJuliana M Valera, Tatyana Diaz, Lauren E Petty, et al.The Lancet. Digital Health|October 17, 2025
Development and validation of a composite digital balance score for spinocerebellar ataxia: a prospective studyJames McNames, Vrutangkumar V Shah, Hannah L Casey, et al.Annals of Clinical and Translational Neurology|September 11, 2023
Propensity matched comparison of omaveloxolone treatment to Friedreich ataxia natural history dataDavid R Lynch, Angie Goldsberry, Christian Rummey, et al.Annals of Neurology|October 17, 2020
Safety and Efficacy of Omaveloxolone in Friedreich Ataxia (MOXIe Study)David R Lynch, Melanie P Chin, Martin B Delatycki, et al.Annals of Clinical and Translational Neurology|March 27, 2019
Randomized, double-blind, placebo-controlled study of interferon-γ 1b in Friedreich AtaxiaDavid R Lynch, Lauren Hauser, Ashley McCormick, et al.Cerebellum (London, England)|August 13, 2025
Best Oculomotor Endpoints for Clinical Trials in Hereditary Ataxias: A Systematic Review and Consensus by the Ataxia Global Initiative Working Group on Digital‑Motor BiomarkersElena Pretegiani, Pilar Garces, Chrystalina A Antoniades, et al.Pageof 19